MedTrace Logo

Dexamethasone Versus Prednisolone in Acute Exacerbation of Childhood Asthma

NCT07275593 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 224

Last updated 2025-12-10

No results posted yet for this study

Summary

Because of insufficient local comparative data, this study was designed to determine the outcome of intravenous dexamethasone in contrast to oral prednisolone in acute exacerbation of asthmatic children.

Conditions

  • Acute Exacerbation of Asthma

Interventions

DRUG

Dexamethasone

Patients received single IV dose of Dexamethasone at a dose of 0.6 mg/kg

DRUG

Prednisolone

Patients received oral prednisone at a dose of 2 mg/kg/day (max 60 mg) as a single dose for 3 days.

Sponsors & Collaborators

  • Muhammad Aamir Latif

    lead OTHER

Principal Investigators

  • Asif Abrar · Nishter Hospital Multan, Pakistan

  • Azam Khan · Nishter Hospital Multan, Pakistan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-11-03
Primary Completion
2025-04-03
Completion
2025-04-03

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07275593 on ClinicalTrials.gov